Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Seri, Yu ^a   Shoda, Hirofumi ^a   Suzuki, Akari ^b   Matsumoto, Isao ^c   Sumida, Takayuki ^c   Fujio, Keishi ^a   Yamamoto, Kazuhiko ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD11B ANTIGEN; GLUCOSE 6 PHOSPHATE ISOMERASE; HYDROLASE; INTERLEUKIN 6; PEPTIDYLARGININE DEIMINASE TYPE IV;

ANIMAL; B LYMPHOCYTE; BLOOD; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMICALLY INDUCED; CYTOLOGY; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; HUMAN; IMMUNIZATION; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE COUNT; METABOLISM; MONOCYTE; NEUTROPHIL; PATHOLOGY; RHEUMATOID ARTHRITIS; SEVERITY OF ILLNESS INDEX; TH17 CELL;

ANIMALS; ANTIBODIES; ANTIGENS, CD11B; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; HYDROLASES; IMMUNIZATION; INTERLEUKIN-6; LYMPHOCYTE COUNT; MICE, KNOCKOUT; MONOCYTES; NEUTROPHILS; SEVERITY OF ILLNESS INDEX; TH17 CELLS;

EID: 84939865143     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13041     Document Type: Article

References (40)

1. Scott, D. L., Wolfe, F. & Huizinga, T. W. Rheumatoid arthritis. Lancet 376, 1094-1108 (2010).
2. McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N Engl J Med 365, 2205-2219 (2011).
3. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376-381 (2013).
4. Suzuki, A. et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34, 395-402 (2003).
5. Eyre, S. et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 44, 1336-1340 (2012).
6. Vossenaar, E. R. et al. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25, 1106-1118 (2003).
7. Chang, X. & Han, J. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. Mol Carcinog 45, 183-196 (2006).
8. Nakashima, K., Hagiwara, T. & Yamada, M. Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J Biol Chem 277, 49562-49568 (2002).
9. Bang, S. Y. et al. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study. Arthritis Res Ther. 12, R115 (2010).
10. Suzuki, T. et al. PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study. PLoS One 8, e61045 (2010).
11. Cuthbert, G. L. et al. Histone deimination antagonizes arginine methylation. Cell 118, 545-553 (2004).
12. Christophorou, M. A. et al. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature 507, 104-108 (2014).
13. Wang, Y. et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306, 279-283 (2004).
14. Guo, Q. & Fast, W. Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53. J Biol Chem 286, 17069-17078 (2011).
15. Yao, H. et al. Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem 283, 20060-20068 (2008).
16. Cui, X. et al. The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest. PLoS One 8, e53791 (2013).
17. Tanikawa, C. et al. Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. Nat Commun 3, 676 (2012).
18. Schubert, D. et al. Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J Immunol 172, 4503-4509 (2004).
19. Tanaka-Watanabe, Y. et al. B cells play a crucial role as antigen-presenting cells and collaborate with inflammatory cytokines in glucose-6-phosphate isomerase-induced arthritis. Clin Exp Immunol 155, 285-294 (2009).
20. Bockermann, R. et al. Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase. Arthritis Res Ther 7, R1316-1324 (2005).
21. Iwanami, K. et al. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase. Arthritis Rheum 58, 754-763 (2008).
22. Willis, V. C. et al. N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol 186, 4396-4404 (2011).
23. Rohrbach, A. S. et al. PAD4 is not essential for disease in the K/BxN murine autoantibody-mediated model of arthritis. Arthritis Res Ther 14, R104 (2012).
24. Shelef, M. A. et al. Peptidylarginine deiminase 4 contributes to tumor necrosis factor alpha induced inflammatory arthritis. Arthritis Rheumatol 66, 1482-1491 (2014).
25. Gottenberg, J. E. et al. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from ESPOIR cohort. Ann Rheum Dis 71, 1243-1248 (2012).
26. Presumey, J. et al. Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis. Ann Rheum Dis 72, 1717-1724 (2013).
27. Pelletier, M. et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115, 335-343 (2010).
28. Nauseef, W. M. & Borregaard, N. Neutrophils at work. Nat Immunol 15, 602-611 (2014).
29. Hurst, S. M. et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14, 705-714 (2001).
30. Jones, G. W. et al. Loss of CD4 + T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J Immunol 184, 2130-2139 (2010).
31. Tillack, K. et al. T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. J Immunol 188, 3150-3159 (2012).
32. Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med 207, 1853-1862 (2010).
33. Pratesi, F. et al. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann Rheum Dis. 73, 1414-1422 (2014).
34. Khandpur, R. et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 5, 178ra40 (2013).
35. Romero, V. et al. Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci Transl Med 5, 209ra150 (2013).
36. Marichal, T. et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 17, 996-1002 (2011).
37. Nakashima, K. et al. PAD4 regulates proliferation of multipotent haematopoietic cells by controlling c-myc expression. Nat Commun 4, 1836 (2013).
38. Matsumoto, I. et al. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum 48, 944-954 (2003).
39. Pettit, A. R. et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159, 1689-1699 (2001).
40. Shoda, H. et al. Detection of autoantibody to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory roles of citrullinated BiP in collagen-induced arthritis. Arthritis Res Ther 13, R191 (2011).